← Back to Clinical Trials
Recruiting NCT07389343

NCT07389343 Effect of a Semirigid Foot Insole in Flexible Pes Planus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07389343
Status Recruiting
Phase
Sponsor Fatma El Zahraa
Condition Flexible Flatfoot or Pes Planus
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-08-27
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Foot Insole

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-08-27 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to investigate the effect of a semirigid foot insole on radiological angle correction in people with asymptomatic flexible flat feet. The X-ray will be performed while standing barefoot one time and the other while standing on the insole from 2 views.

Eligibility Criteria

Inclusion Criteria: 1. Asymptomatic people with flexible pes planus. If the pain is greater than 3 out of 10 on the visual analog scale in the last 3 months, the patient is considered to have symptomatic flat feet (Mahdiyar et al., 2021). 2. Aged 18-35. 3. BMI max 29.9 kg/cm². Exclusion Criteria: 1. Osteoarthritis of the joints of the foot (excluded by x-ray). 2. Foot Deformities (e.g. Hallux Valgus) 3. Old fractures of the foot. 4. Previous injuries to the ankle. 5. Previous surgeries to the lower limb. 6. Calcaneal Spur. 7. Foot and ankle ligaments tear. 8- Systemic diseases such as rheumatoid arthritis. (Gouty arthritis, autoimmune disease) 9. Neurological diseases.

Contact & Investigator

Central Contact

Fatma Elzahraa A ElBayomi, MSc degree

✉ fatmaelzahraaelbayomi@gmail.com

📞 +201140015529

Principal Investigator

Fatma Elzahraa A ElBayomi, MSc degree

PRINCIPAL INVESTIGATOR

Cairo University

Frequently Asked Questions

Who can join the NCT07389343 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Flexible Flatfoot or Pes Planus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07389343 currently recruiting?

Yes, NCT07389343 is actively recruiting participants. Contact the research team at fatmaelzahraaelbayomi@gmail.com for enrollment information.

Where is the NCT07389343 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT07389343 clinical trial?

NCT07389343 is sponsored by Fatma El Zahraa. The principal investigator is Fatma Elzahraa A ElBayomi, MSc degree at Cairo University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology